Daily Statin Lowers Cardiovascular Risk in People With HIV
The National Institutes of Health (NIH) halted a clinical trial early after discovering that daily statin medication significantly reduced cardiovascular disease risk in people living with HIV. The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) study revealed that participants taking pitavastatin calcium lowered their risk of major adverse cardiovascular events by 35% compared to those on a placebo. The study involved 7,769 volunteers aged 40 to 75 from 12 countries, all of whom were taking antiretroviral…